Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Previously Treated Advanced Colorectal Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 17 of 0 results

Testing effectiveness (Phase 2)UnknownNCT05799443
What this trial is testing

Efficacy and Safety of SBRT Followed by Tislelizumab Plus Cetuximab and Irinotecan in Patients With Previously Treated RAS Wild-type Advanced Refractory Colorectal Cancer

Who this might be right for
Colorectal Cancer
Fujian Cancer Hospital 23
Testing effectiveness (Phase 2)Study completedNCT00005050
What this trial is testing

Eniluracil, Fluorouracil, and Oxaliplatin in Treating Patients With Advanced Colorectal Cancer

Who this might be right for
Colorectal Cancer
NYU Langone Health
Testing effectiveness (Phase 2)Ended earlyNCT05330429
What this trial is testing

Study of Magrolimab Given Together With FOLFIRI/Bevacizumab (BEV) in Participants With Previously Treated Advanced Inoperable Metastatic Colorectal Cancer (mCRC)

Who this might be right for
Metastatic Colorectal Cancer
Gilead Sciences 77
Large-scale testing (Phase 3)Study completedNCT04472429
What this trial is testing

Carboplatin-paclitaxel With Retifanlimab or Placebo in Participants With Locally Advanced or Metastatic Squamous Cell Anal Carcinoma (POD1UM-303/InterAACT 2).

Who this might be right for
Squamous Cell Carcinoma of the Anal Canal
Incyte Corporation 308
Early research (Phase 1)Study completedNCT04430842
What this trial is testing

Dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of QBS10072S

Who this might be right for
AstrocytomaBrain CancerBrain Metastases+20 more
Quadriga Biosciences, Inc. 15
Early research (Phase 1)UnknownNCT00777478
What this trial is testing

Capiri-sutent Phase-1 in Advanced Colo-rectal Cancer

Who this might be right for
Colorectal Cancer
Radboud University Medical Center 32
Testing effectiveness (Phase 2)Study completedNCT01676714
What this trial is testing

Study of Dovitinib and Biomarkers in Advanced Non-Small Cell Lung Cancer or Advanced Colorectal Cancer

Who this might be right for
Non-Small Cell Lung CancerColorectal Cancer
University of California, Davis 10
Early research (Phase 1)Study completedNCT00003427
What this trial is testing

Oxaliplatin Plus Irinotecan in Treating Patients With Metastatic Gastrointestinal Cancer

Who this might be right for
Anal CancerColorectal CancerEsophageal Cancer+7 more
Memorial Sloan Kettering Cancer Center 36
Large-scale testing (Phase 3)Study completedNCT00003873
What this trial is testing

Fluorouracil With or Without Eniluracil in Treating Patients With Advanced Colorectal Cancer

Who this might be right for
Adenocarcinoma of the ColonAdenocarcinoma of the RectumRecurrent Colon Cancer+3 more
National Cancer Institute (NCI) 950
Early research (Phase 1)Looking for participantsNCT07020117
What this trial is testing

[225Ac]Ac-AKY-1189 in Patients With Solid Tumors

Who this might be right for
Urothelial Carcinoma BladderTriple Negative Breast Cancer (TNBC)Hormone Receptor Positive Breast Adenocarcinoma+4 more
Aktis Oncology, Inc. 150
Early research (Phase 1)Study completedNCT00161187
What this trial is testing

Irradiated Donor Lymphocyte Infusion in Treating Patients With Relapsed or Refractory Hematologic Cancer or Solid Tumor

Who this might be right for
Cancer
University of Medicine and Dentistry of New Jersey 37
Testing effectiveness (Phase 2)Looking for participantsNCT06558773
What this trial is testing

GSL Synthetase Inhibitor Plus Immune Checkpoint Inhibitor and/or Regorafenib in Previously Treated pMMR/MSS CRC.

Who this might be right for
Colorectal Cancer
Chinese PLA General Hospital 120
Testing effectiveness (Phase 2)Study completedNCT00077337
What this trial is testing

FR901228 in Treating Patients With Previously Treated Unresectable Locally Advanced or Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
SWOG Cancer Research Network
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07743723
What this trial is testing

IOV-5001 in Adults With Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorsNon-Small Cell Lung CancerTriple Negative Breast Cancer (TNBC)+4 more
Iovance Biotherapeutics, Inc. 106
Early research (Phase 1)Not Yet RecruitingNCT07411781
What this trial is testing

PIN in Combination With Sintilimab in Previously Treated pMMR/MSS CRC With Hepatic Metastases

Who this might be right for
Colorectal CancerAdult
Chinese PLA General Hospital 25
Testing effectiveness (Phase 2)Study completedNCT01814501
What this trial is testing

Panitumumab and Chemotherapy in Patients With Advanced Colorectal Cancer After Prior Therapy With Bevacizumab

Who this might be right for
Mucinous Adenocarcinoma of the ColonMucinous Adenocarcinoma of the RectumRecurrent Colon Cancer+5 more
John Hays 16
Early research (Phase 1)Study completedNCT01304602
What this trial is testing

A Trial of Irinotecan and BKM120 in Previously Treated Advanced Colorectal Cancer

Who this might be right for
Colorectal Cancer
University of Kansas Medical Center 20